These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19174293)

  • 1. Mefloquine neurotoxicity: a literature review.
    Toovey S
    Travel Med Infect Dis; 2009 Jan; 7(1):2-6. PubMed ID: 19174293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of artemisinins and amino alcohol partner antimalarials on mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase activity.
    Toovey S; Bustamante LY; Uhlemann AC; East JM; Krishna S
    Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):209-13. PubMed ID: 18684232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report.
    Tran TM; Browning J; Dell ML
    Malar J; 2006 Aug; 5():74. PubMed ID: 16925829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine.
    van Riemsdijk MM; Sturkenboom MC; Ditters JM; Tulen JH; Ligthelm RJ; Overbosch D; Stricker BH
    Br J Clin Pharmacol; 2004 Apr; 57(4):506-12. PubMed ID: 15025750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood mefloquine-induced mania and psychosis: a case report.
    Thapa R; Biswas B
    J Child Neurol; 2009 Aug; 24(8):1008-9. PubMed ID: 19295181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric events during prophylactic use of mefloquine before travelling.
    van Riemsdijk MM; Ditters JM; Sturkenboom MC; Tulen JH; Ligthelm RJ; Overbosch D; Stricker BH
    Eur J Clin Pharmacol; 2002 Sep; 58(6):441-5. PubMed ID: 12242605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mefloquine: neuropsychiatric adverse effects are often severe and persistent long after withdrawal of the drug].
    Jensen JJ
    Ugeskr Laeger; 1998 Apr; 160(16):2413. PubMed ID: 9616091
    [No Abstract]   [Full Text] [Related]  

  • 9. Mefloquine-induced pneumonitis.
    Soentjens P; Delanote M; Van Gompel A
    J Travel Med; 2006; 13(3):172-4. PubMed ID: 16706949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymorphism at the MDR1 locus as a cause of mefloquine-induced psychosis].
    Zaigraykina N; Potasman I
    Harefuah; 2010 Sep; 149(9):583-4, 620, 619. PubMed ID: 21302473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible hearing loss in temporal association with chemoprophylactic mefloquine use.
    Wise M; Toovey S
    Travel Med Infect Dis; 2007 Nov; 5(6):385-8. PubMed ID: 17983978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional profiling of mefloquine-induced disruption of calcium homeostasis in neurons in vitro.
    Dow GS; Caridha D; Goldberg M; Wolf L; Koenig ML; Yourick DL; Wang Z
    Genomics; 2005 Nov; 86(5):539-50. PubMed ID: 16109470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mefloquine-induced eosinophilic pneumonia.
    Katsenos S; Psathakis K; Nikolopoulou MI; Constantopoulos SH
    Pharmacotherapy; 2007 Dec; 27(12):1767-71. PubMed ID: 18041895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limbic encephalopathy and central vestibulopathy caused by mefloquine: a case report.
    Nevin RL
    Travel Med Infect Dis; 2012 May; 10(3):144-51. PubMed ID: 22494697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis.
    Alisky JM; Chertkova EL; Iczkowski KA
    Med Hypotheses; 2006; 67(5):1090-4. PubMed ID: 16843615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous reports of psychiatric adverse effects to mefloquine in the Netherlands.
    van Riemsdijk MM; van der Klauw MM; Pepplinkhuizen L; Stricker BH
    Br J Clin Pharmacol; 1997 Jul; 44(1):105-6. PubMed ID: 9241106
    [No Abstract]   [Full Text] [Related]  

  • 17. Paranoid psychosis related to mefloquine antimalarial prophylaxis.
    Fuller SJ; Naraqi S; Gilessi G
    P N G Med J; 2002; 45(3-4):219-21. PubMed ID: 12968793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuropsychiatric symptoms caused by mefloquine (report of several cases)].
    Murai Z; Baran B; Tolna J; Szily E; Gazdag G
    Orv Hetil; 2005 Jan; 146(3):133-6. PubMed ID: 15693445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.
    Riganti C; Doublier S; Viarisio D; Miraglia E; Pescarmona G; Ghigo D; Bosia A
    Br J Pharmacol; 2009 Apr; 156(7):1054-66. PubMed ID: 19298255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprophylaxis according to the guidelines on malaria prevention for Japanese overseas travelers.
    Mizuno Y; Kudo K; Kano S
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():11-4. PubMed ID: 17547042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.